EDGAR Filing Documents for 0001367644-14-000007

Form 8-K - Current report:

SEC Accession No. 0001367644-14-000007

Filing Date

2014-01-29

Accepted

2014-01-29 16:06:21

Documents

Period of Report

2014-01-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	27913
2		exhibit4-1.htm	EX-4.1	581331
3		exhibit10.htm	EX-10	299413
4		exhibit99-1.htm	EX-99.1	10885
5		exhibit99-2.htm	EX-99.2	7077
6		image1.jpg	GRAPHIC	3083
7		image2.jpg	GRAPHIC	4013
8		image3.jpg	GRAPHIC	3901
9		image4.jpg	GRAPHIC	4184
10		image5.jpg	GRAPHIC	3231
11		image6.jpg	GRAPHIC	4945
	Complete submission text file	0001367644-14-000007.txt		960824

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850

Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800

Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)